Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PI3K/mTOR Inhibitor-1

Copy Product Info
😃Good
Catalog No. T12460Cas No. 1949802-49-6

PI3K/mTOR Inhibitor-1 is a potent, orally bioavailable dual inhibitor of PI3K/mTOR (PI3Kα/PI3Kβ/PI3Kδ/PI3Kγ/mTOR with IC50s of 20/376/204/46/186 nM).

PI3K/mTOR Inhibitor-1

PI3K/mTOR Inhibitor-1

Copy Product Info
😃Good
Catalog No. T12460Cas No. 1949802-49-6
PI3K/mTOR Inhibitor-1 is a potent, orally bioavailable dual inhibitor of PI3K/mTOR (PI3Kα/PI3Kβ/PI3Kδ/PI3Kγ/mTOR with IC50s of 20/376/204/46/186 nM).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$2,1208-10 weeks8-10 weeks
50 mg$2,7808-10 weeks8-10 weeks
100 mg$3,7008-10 weeks8-10 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
PI3K/mTOR Inhibitor-1 is a potent, orally bioavailable dual inhibitor of PI3K/mTOR (PI3Kα/PI3Kβ/PI3Kδ/PI3Kγ/mTOR with IC50s of 20/376/204/46/186 nM).
Targets&IC50
PI3Kδ:46 nM, PI3Kα:20 nM, PI3Kβ:376 nM, PI3Kγ:204 nM, mTOR:186 nM
In vitro
PI3K/mTOR Inhibitor-1 (Compound 26) is a potent dual PI3K/mTOR inhibitor, demonstrating high inhibitory activity against PI3Kα/β/γ/δ (IC50 = 20/376/204/46 nM) and mTOR (IC50 = 189 nM), potent suppression of AKT phosphorylation (IC50 = 196 nM), and excellent antiproliferative effects on cancer cells. Enzymic data and modeling simulations indicate that a cyclopropyl ring on the C4 sulfone chain and a fluorine on the C6 aminopyridyl moiety are responsible for its maintained PI3K activity and enhanced mTOR potency, respectively.
In vivo
PI3K/mTOR Inhibitor-1 (Compound 26) demonstrated superior antiproliferative effects in the HT-29 colorectal carcinoma xenograft model at daily doses of 3.75 and 7.5 mg/kg compared to BKM120 at doses of 15 and 30 mg/kg.
Chemical Properties
Molecular Weight407.46
FormulaC18H22FN5O3S
Cas No.1949802-49-6
SmilesS(C)(=O)(=O)C1(CC1)C=2C=C(N=C(N2)N3[C@@H](C)COCC3)C=4C(F)=CC(N)=NC4
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PI3K/mTOR Inhibitor-1 | purchase PI3K/mTOR Inhibitor-1 | PI3K/mTOR Inhibitor-1 cost | order PI3K/mTOR Inhibitor-1 | PI3K/mTOR Inhibitor-1 chemical structure | PI3K/mTOR Inhibitor-1 in vivo | PI3K/mTOR Inhibitor-1 in vitro | PI3K/mTOR Inhibitor-1 formula | PI3K/mTOR Inhibitor-1 molecular weight